Beijing, May 12 (Prensa Latina) China and Cuba decided today to accelerate a project that will lead to the first joint biotechnology park to research, develop, produce and market drugs obtained in the Caribbean state, of proven efficacy and worldwide recognition.
The island’s ambassador here, Carlos Miguel Pereira, and Huang Liansheng, president of the Guangxi Fukang Medical Investment and Management Co Ltd; agreed that this is a key and priority work for bilateral cooperation.
They emphasized the importance of resuming and fulfilling the steps previously agreed upon in order to proceed with the preparation of the facilities and deployment of Cuban experts in the new stage.
Pereira considered that the construction of the biotechnology park will pave the way for other large-scale plans in a sector where both countries have solid ties.
He thanked the Guangxi Fukang for its efforts to give it a boost and highlighted its greater relevance because it coincides with other initiatives by Cuba and the top health, science and technology institutions in China, aimed at developing certain products and therapies that can be linked to joint cooperation with third countries.
For his part, Huang reported that the project is among the main ones in the Zhuang autonomous region of Guangxi (south), the local government promised preferential policies, full support and has already handed over 33 hectares of land for the first facilities.
The biotechnology park is an agreement between the Biocubafarma group and Guangxi Fukang, and will be installed in the Fangchenggang Development Zone, which has the prospect of becoming an experimental industrial pole in research and obtaining medicines for China and the Association of Southeast Asian Nations.